Cancer stem cell theory and the warburg effect, two sides of the same Coin?

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8893-8930

  Pacini, Nicola ^a   Borziani, Fabio ^a  

^a Laboratorio Privato di Biochimica F Pacini   (Italy)

Author keywords

Aerobic glycolysis; Atp; Cancer; Cancer stem cells; Cancerogenesis; Differentiation; Dissipative structure; Entropy; Epigenetic modulation; Epithelial mesenchymal transition; Free energy; Glycolysis; Human embryonic stem cells; Induced pluripotent stem cells; Mitochondria; Oxidative phosphorylation; Self renewal; Warburg effect

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; GLUTATHIONE; GLUTATHIONE DISULFIDE; HISTONE H3; HYPOXIA INDUCIBLE FACTOR 1; LACTATE DEHYDROGENASE; OXYGEN; PROTEIN P53; PYRUVATE KINASE; REACTIVE OXYGEN METABOLITE; S ADENOSYLMETHIONINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER STEM CELL; CANCER STEM CELL THEORY; CELL CYCLE; CELL DIFFERENTIATION; DNA REPAIR; ENERGY METABOLISM; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; GLYCOLYSIS; HEALTH SURVEY; HUMAN; HYPOTHESIS; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN TENSION; POPULATION DYNAMICS; SACCHAROMYCES CEREVISIAE; STOCHASTIC MODEL; THERMODYNAMICS; TUMOR CELL; TUMOR MICROENVIRONMENT; WARBURG EFFECT; DRUG RESISTANCE; METABOLISM; NEOPLASMS; PATHOLOGY; THEORETICAL MODEL;

ANTINEOPLASTIC AGENTS; CELLULAR MICROENVIRONMENT; DRUG RESISTANCE, NEOPLASM; GLYCOLYSIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; MODELS, THEORETICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; THERMODYNAMICS;

EID: 84901005340     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058893     Document Type: Article

References (284)

1. Jacob, F.; Morton, K. The transmission of leukemia of mice with a single cell. Am. J. Cancer 1937, 31, 276-282.
2. Kruse, J.P.; Gu, W. Modes of p53 regulation. Cell 2009, 137, 609-622.
3. Olovnikov, I.A.; Kravchenko, J.E.; Chumakov, P.M. Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense. Semin. Cancer Biol. 2009, 19, 32-41.
4. Sonnenschein, C.; Soto, A.M. Somatic mutation theory of carcinogenesis: Why it should be dropped and replaced. Mol. Carcinog. 2000, 29, 205-211.
5. Loeb, L.A. A mutator phenotype in Cancer. Cancer Res. 2001, 61, 3230-3239.
6. Nowell, P.C. Tumor progression: A brief historical perspective. Semin. Cancer Biol. 2002, 12, 261-266.
7. Baker, S.G.; Kramer, B.S. Paradoxes in carcinogenesis: New opportunities for research directions. BMC Cancer 2007, 7, 151.
8. Mori, H.; Colman, S.M.; Xiao, Z.; Ford, A.M.; Healy, L.E.; Donaldson, C.; Hows, J.M.; Navarrete, C.; Greaves, M. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA 2002, 99, 8242-8247.
9. Sengupta, A.; Cancelas, J.A. Cancer stem cells: A stride towards cancer cure? J. Cell Physiol. 2010, 225, 7-14.
10. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M.A.; Dick, J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367, 645-648.
11. Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic. Cell. Nat. Med. 1997, 3, 730-737.
12. Al-Hajj, M. Cancer stem cells and oncology therapeutics. Curr. Opin. Oncol. 2007, 19, 61-64.
13. Singh, S.K.; Clarke, I.D.; Terasaki, M.; Bonn, V.E.; Hawkins, C.; Squire, J.; Dirks, P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63, 5821-5828.
14. He, J.; Liu, Y.; Lubman, D.M. Targeting glioblastoma stem cells: Cell surface markers. Curr. Med. Chem. 2012, 19, 6050-6055.
15. O'Flaherty, J.D.; Barr, M.; Fennell, D.; Richard, D.; Reynolds, J.; O'Leary, J.; O'Byrne, K. The cancer stem-cell hypothesis: Its emerging role in lung cancer biology and its relevance for future therapy. J. Thorac. Oncol. 2012, 7, 1880-1890.
16. Dhawan, P.; Ahmad, R.; Srivastava, A.S.; Singh, A.B. Cancer stem cells and colorectal cancer: An overview. Curr. Top. Med. Chem. 2011, 11, 1592-1598.
17. Zhang, S.; Balch, C.; Chan, M.W.; Lai, H.C.; Matei, D.; Schilder, J.M.; Yan, P.S.; Huang, T.H.; Nephew, K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68, 4311-4320.
18. Ahmed, N.; Abubaker, K.; Findlay, J.K. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets. Mol. Aspects Med. 2013, 2013, doi:10.1016/j.mam.2013.06.002.
19. Gou, S.; Liu, T.; Wang, C.; Yin, T.; Li, K.; Yang, M.; Zhou, J. Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 2007, 34, 429-435.
20. Hamada, S.; Masamune, A.; Takikawa, T.; Suzuki, N.; Kikuta, K.; Hirota, M.; Hamada, H.; Kobune, M.; Satoh, K.; Shimosegawa, T. Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2012, 421, 349-354.
21. Lang, S.H.; Frame, F.M.; Collins, A.T. Prostate cancer stem cells. J. Pathol. 2009, 217, 299-306.
22. Malaguarnera, R.; Frasca, F.; Garozzo, A.; Gianì, F.; Pandini, G.; Vella, V.; Vigneri, R.; Belfiore, A. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J. Clin. Endocrinol. Metab. 2010, 96, 766-774.
23. Lorico, A.; Rappa, G. Phenotypic heterogeneity of breast cancer stem cells. J. Oncol. 2011, 2011, doi:10.1155/2011/135039.
24. Curtin, J.C.; Lorenzi, M.V. Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 2010, 1, 552-566.
25. Xia, T.; Jiang, H.; Li, C.; Tian, M.; Zhang, H. Molecular imaging in tracking tumor stem-like cells. J. Biomed. Biotechnol. 2012, 2012, doi:10.1155/2012/420364.
26. Cukierman, E.; Bassi, D.E. The mesenchymal tumor microenvironment: A drug-resistant niche. Cell Adh. Migr. 2012, 6, 285-296.
27. Sell, S. On the stem cell origin of Cancer. Am. J. Pathol. 2010, 176, 2584-2594.
28. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105-111.
29. Peitzsch, C.; Kurth, I.; Kunz-Schughart, L.; Baumann, M.; Dubrovska, A. Discovery of the cancer stem cell related determinants of radioresistance. Radiother. Oncol. 2013, 108, 378-387.
30. Wicha, M.S.; Liu, S.; Dontu, G. Cancer stem cells: An old idea-A paradigm shift. Cancer Res. 2006, 66, 1883-1890.
31. Siggins, R.W.; Zhang, P.; Welsh, D.; Lecapitaine, N.J.; Nelson, S. Stem cells, phenotypic inversion, and differentiation. Int. J. Clin. Exp. Med. 2008, 1, 2-21.
32. Kondoh, H.; Lleonart, M.E.; Bernard, D.; Gil, J. Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol. Histopathol. 2007, 22, 85-90.
33. Kondoh, H.; Lleonart, M.E.; Nakashima, Y.; Yokode, M.; Tanaka, M.; Bernard, D.; Gil, J.; Beach, D. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid. Redox Signal. 2007, 9, 293-299.
34. Kraft, C.S.; LeMoine, C.M.; Lyons, C.N.; Michaud, D.; Mueller, C.R.; Moyes, C.D. Control of mitochondrial biogenesis during myogenesis. Am. J. Physiol. Cell Physiol. 2006, 290, C1119-C1127.
35. Chen, C.T.; Shih, Y.R.; Kuo, T.K.; Lee, O.K.; Wei, Y.H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26, 960-968.
36. Stringari, C.; Edwards, R.A.; Pate, K.T.; Waterman, M.L.; Donovan, P.J.; Gratton, E. Metabolic trajectory of cellular differentiation in small intestine by phasor fluorescence lifetime microscopy of NADH. Sci. Rep. 2012, 2, doi:10.1038/srep00568.
37. Wright, B.K.; Andrews, L.M.; Markham, J.; Jones, M.R.; Stringari, C.; Digman, M.A.; Gratton, E. NADH distribution in live progenitor stem cells by phasor-fluorescence lifetime image microscopy. Biophys. J. 2012, 103, L7-L9.
38. Sen, A.; Damm, V.T.; Cox, R.T. Drosophila clueless is highly expressed in larval neuroblasts, affects mitochondrial localization and suppresses mitochondrial oxidative damage. PLoS One 2013, 8, doi:10.1371/journal.pone.0054283.
39. Legname, A.H.; Salomón de Legname, H. Changes in the oxidative metabolism during maturation of amphibian oocytes. J. Embryol. Exp. Morphol. 1980, 59, 175-186.
40. Wales, R.G. Measurement of metabolic turnover in single mouse embryos. J. Reprod. Fertil. 1986, 76, 717-725.
41. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
42. Nelson, T.J.; Terzic, A. Induced pluripotent stem cells: An emerging theranostics platform. Clin. Pharmacol. Ther. 2011, 89, 648-650.
43. Prigione, A.; Adjaye, J. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int. J. Dev. Biol. 2010, 54, 1729-1741.
44. Vazquez-Martin, A.; Corominas-Faja, B.; Cufi, S.; Vellon, L.; Oliveras-Ferraros, C.; Menendez, O.J.; Joven, J.; Lupu, R.; Menendez, J.A. The mitochondrial H+-ATP synthase and the lipogenic switch: New core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle 2013, 12, 207-218.
45. Folmes, C.D.; Nelson, T.J.; Terzic, A. Energy metabolism in nuclear reprogramming. Biomark. Med. 2011, 5, 715-729.
46. Panopoulos, A.D.; Yanes, O.; Ruiz, S.; Kida, Y.S.; Diep, D.; Tautenhahn, R.; Herrerías, A.; Batchelder, E.M.; Plongthongkum, N.; Lutz, M., et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 2012, 22, 168-177.
47. Westermann, B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010, 11, 872-884.
48. Varum, S.; Momcilović, O.; Castro, C.; Ben-Yehudah, A.; Ramalho-Santos, J.; Navara, C.S. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res. 2009, 3, 142-156.
49. Folmes, C.D.; Nelson, T.J.; Martinez-Fernandez, A.; Arrell, D.K.; Lindor, J.Z.; Dzeja, P.P.; Ikeda, Y.; Perez-Terzic, C.; Terzic, A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14, 264-271.
50. Ding, D.F.; Li, X.F.; Xu, H.; Wang, Z.; Liang, Q.Q.; Li, C.G.; Wang, Y.J. Mechanism of resveratrol on the promotion of induced pluripotent stem cells. J. Integr. Med. 2013, 11, 389-396.
51. Varum, S.; Rodrigues, A.S.; Moura, M.B.; Momcilovic, O.; Easley, C.A., 4th.; Ramalho-Santos, J.; van Houten, B.; Schatten, G. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 2011, 6, doi:10.1371/journal.pone.0020914.
52. Abu Dawud, R.; Schreiber, K.; Schomburg, D.; Adjaye, J. Human embryonic stem cells and embryonal carcinoma cells have overlapping and distinct metabolic signatures. PLoS One 2012, 7, doi:10.1371/journal.pone.0039896.
53. Palorini, R.; Votta, G.; Balestrieri, C.; Monestiroli, A.; Olivieri, S.; Vento, R.; Chiaradonna, F. Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS. J. Cell Biochem. 2014, 115, 368-379.
54. Huber, M.A.; Kraut, N.; Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17, 548-558.
55. Tarin, D.; Thompson, E.W.; Newgreen, D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005, 65, 5996-6000.
56. Smith, D.G.; Sturmey, R.G. Parallels between embryo and cancer cell metabolism. Biochem. Soc. Trans. 2013, 41, 664-669.
57. Warburg, O.; Wind, F.; Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 1927, 8, 519-530.
58. Tennant, D.A.; Durán, R.V.; Gottlieb, E. Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 2010, 10, 267-277.
59. Warburg, O. On respiratory impairment in cancer cells. Science 1956, 124, 269-270.
60. Seyfried, T.N., Shelton, L.M. Cancer as a metabolic disease. Nutr. Metab. 2010, 7, doi:10.1186/1743-7075-7-7.
61. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029-1033.
62. Gatenby, R.A.; Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891-899.
63. Lynen, F. Die rolle der phosphorsaeure bei dehydrierungsvorgaengen und ihre biologische bedeutung. Naturwissenschaften. 1951, 30, 398-406. (In German)
64. Kim, J.W.; Dang, C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006, 66, 8927-8930.
65. Fantin, V.R.; St-Pierre, J.; Leder, P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006, 9, 425-434.
66. Patel, M.S.; Korotchkina, L.G. Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: Complexity of multiple phosphorylation sites and kinases. Exp. Mol. Med. 2001, 33, 191-197.
67. Goetze, K.; Walenta, S.; Ksiazkiewicz, M.; Kunz-Schughart, L.A.; Mueller-Klieser, W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int. J. Oncol. 2011, 39, 453-463.
68. Hirschhaeuser, F.; Sattler, U.G.; Mueller-Klieser, W. Lactate: A metabolic key player in cancer. Cancer Res. 2011, 71, 6921-6925.
69. Végran, F.; Boidot, R.; Michiels, C.; Sonveaux, P.; Feron, O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 2011, 71, 2550-2560.
70. Kennedy, K.M.; Dewhirst, M.W. Tumor metabolism of lactate: The influence and therapeutic potential for MCT and CD147 regulation. Futur. Oncol. 2010, 6, 127-148.
71. Walenta, S.; Mueller-Klieser, W.F. Lactate: Mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 2004, 14, 267-274.
72. Eigentler, T.K.; Figl, A.; Krex, D.; Mohr, P.; Mauch, C.; Rass, K.; Bostroem, A.; Heese, O.; Koelbl, O.; Garbe, C., et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011, 117, 1697-1703.
73. Koukourakis, M.I.; Giatromanolaki, A.; Sivridis, E.; Gatter, K.C.; Trarbach, T.; Folprecht, G.; Shi, M.M.; Lebwohl, D.; Jalava, T.; Laurent, D., et al. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin. Cancer Res. 2011, 17, 4892-4900.
74. Li, G.; Gao, J.; Tao, Y.L.; Xu, B.Q.; Tu, Z.W.; Liu, Z.G.; Zeng, M.S.; Xia, Y.F. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin. J. Cancer 2012, 31, 197-206.
75. Xie, H.; Valera, V.A.; Merino, M.J.; Amato, A.M.; Signoretti, S.; Linehan, W.M.; Sukhatme, V.P.; Seth, P. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell Cancer. Mol. Cancer Ther. 2009, 8, 626-635.
76. Szanto, I.; Rubbia-Brandt, L.; Kiss, P.; Steger, K.; Banfi, B.; Kovari, E.; Herrmann, F.; Hadengue, A.; Krause, K.H. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J. Pathol. 2005, 207, 164-176.
77. Kawahara, T.; Lambeth, J.D. Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes. BMC Evol. Biol. 2007, 7, 178.
78. Lu, W.; Hu, Y.; Chen, G.; Chen, Z.; Zhang, H.; Wang, F.; Feng, L.; Pelicano, H.; Wang, H.; Keating, M.J., et al. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol. 2012, 10, doi:10.1371/journal.pbio.1001326.
79. Lin, C.C.; Cheng, T.L.; Tsai, W.H.; Tsai, H.J.; Hu, K.H.; Chang, H.C.; Yeh, C.W.; Chen, Y.C.; Liao, C.C.; Chang, W.T. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci. Rep. 2012, 2, doi:10.1038/srep00785.
80. Singh, M.; Singh, V.N.; August, J.T.; Horecker, B.L. Alterations in glucose metabolism in chick embryo cells transformed by Rous sarcoma virus. Transformation-specific changes in the activities of key enzymes of the glycolytic and hexose monophosphate shunt pathways. Arch. Biochem. Biophys.1974, 165, 240-246.
81. Darekar, S.; Georgiou, K.; Yurchenko, M.; Yenamandra, S.P.; Chachami, G.; Simos, G.; Klein, G.; Kashuba, E. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS One 2012, 7, doi:10.1371/journal.pone.0042072.
82. Cole, M.A.; Crawford, D.W.; Warner, N.E.; Puffer, H.W. Correlation of regional disease and in vivo PO2 in rat mammary adenocarcinoma. Am. J. Pathol. 1983, 112, 61-67.
83. Joyce, R.M.; Vincent, P.C. Advantage of reduced oxygen tension in growth of human melanomas in semi-solid cultures: Quantitative analysis. Br. J. Cancer 1983, 48, 385-393.
84. Ezashi, T.; Das, P.; Roberts, R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. USA 2005, 102, 4783-4788.
85. Yoshida, Y.; Takahashi, K.; Okita, K.; Ichisaka, T.; Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5, 237-241.
86. Brizel, D.M.; Sibley, G.S.; Prosnitz, L.R.; Scher, R.L.; Dewhirst, M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38, 285-289.
87. Nozue, M.; Lee, I.; Yuan, F.; Teicher, B.A.; Brizel, D.M.; Dewhirst, M.W.; Milross, C.G.; Milas, L.; Song, C.W.; Thomas, C.D., et al. Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J. Surg. Oncol. 1997, 66, 30-38.
88. Nordsmark, M.; Høyer, M.; Keller, J.; Nielsen, O.S.; Jensen, O.M.; Overgaard, J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 1996, 35, 701-708.
89. Sundfør, K.; Lyng, H.; Rofstad, E.K. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br. J. Cancer 1998, 78, 822-827.
90. Nordsmark, M.; Overgaard, J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother. Oncol. 2000, 57, 39-43.
91. Young, S.D.; Marshall R.S., Hill, R.P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 1988, 85, 9533-9537.
92. Young, S.D.; Hill, R.P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: Anticancer drug sensitivity and metastatic potential. J. Natl. Cancer Inst. 1990, 82, 371-380.
93. Rofstad, E.K.; Måseide, K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 1999, 75, 1377-1393.
94. Olsen, D.R.; Singstad, T.E.; Rofstad, E.K. Effects of hyperthermia on bioenergetic status and phosphorus T1S in human melanoma xenografts monitored by 31P-MRS. Magn. Reson. Imaging. 1999, 17, 1049-1056.
95. Stackpole, C.W.; Groszek, L.; Kalbag, S.S. Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J. Natl. Cancer Inst. 1994, 86, 361-367.
96. Graham, C.H.; Forsdike, J.; Fitzgerald, C.J.; Macdonald-Goodfellow, S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer 1999, 80, 617-623.
97. Ebos, J.M.; Lee, C.R.; Cruz-Munoz, W.; Bjarnason, G.A.; Christensen, J.G.; Kerbel, R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009, 15, 232-239.
98. Pfeiffer, T.; Schuster, S.; Bonhoeffer, S. Cooperation and competition in the evolution of ATP-producing pathways. Science 2001, 292, 504-507.
99. DeBerardinis, R.J.; Mancuso, A.; Daikhin, E.; Nissim, I.; Yudkoff, M.; Wehrli, S.; Thompson, C.B. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 2007, 104, 19345-19350.
100. Cairns, R.A.; Kalliomaki, T.; Hill, R.P. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 2001, 61, 8903-8908.
101. Knudson, A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 2001, 1, 157-162.
102. Bertram, J.S. The molecular biology of cancer. Mol. Aspects Med. 2000, 21, 167-223.
103. Roach, J.C.; Glusman, G.; Smit, A.F.; Huff, C.D.; Hubley, R.; Shannon, P.T.; Rowen, L.; Pant, K.P.; Goodman, N.; Bamshad, M., et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010, 328, 636-639.
104. Hitchler, M.J.; Domann, F.E. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic. Biol. Med. 2009, 47, 115-127.
105. Hitchler, M.J.; Domann, F.E. Redox regulation of the epigenetic landscape in cancer: A role for metabolic reprogramming in remodeling the epigenome. Free Radic. Biol. Med. 2012, 53, 2178-2187.
106. Gambini, J.; Gomez-Cabrera, M.C.; Borras, C.; Valles, S.L.; Lopez-Grueso, R.; Martinez-Bello, V.E.; Herranz, D.; Pallardo, F.V.; Tresguerres, J.A.; Serrano, M., et al. Free [NADH]/[NAD(+)] regulates sirtuin expression. Arch. Biochem. Biophys. 2011, 512, 24-29.
107. Van Horssen, R.; Willemse, M.; Haeger, A.; Attanasio, F.; Güneri, T.; Schwab, A.; Stock, C.M.; Buccione, R.; Fransen, J.A.; Wieringa, B. Intracellular NAD(H) levels control motility and invasion of glioma cells. Cell Mol. Life Sci.2013, 70, 2175-2190.
108. Mato, J.M.; Lu, S.C. The hepatocarcinogenic effect of methionine and choline deficient diets: An adaptation to the Warburg effect? Alcohol Clin. Exp. Res. 2011, 35, 811-814.
109. Mato, J.M.; Lu, S.C. S-adenosylmethionine in liver health, injury, and cancer. Physiol. Rev. 2012, 92, 1515-1542.
110. Watson, W.H.; Song, Z.; Kirpich, I.A.; Deaciuc, I.V.; Chen, T.; McClain, C.J. Ethanol exposure modulates hepatic S-adenosylmethionine and S-adenosylhomocysteine levels in the isolated perfused rat liver through changes in the redox state of the NADH/NAD(+) system. Biochim. Biophys. Acta 2011, 1812, 613-618.
111. Yang, W.; Zheng, Y.; Xia, Y.; Ji, H.; Chen, X.; Guo, F.; Lyssiotis, C.A.; Aldape, K.; Cantley, L.C.; Lu, Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 2012, 14, 1295-1304.
112. Neary, C.L.; Pastorino, J.G. Nucleocytoplasmic shuttling of hexokinase II in a cancer cell. Biochem. Biophys. Res. Commun. 2010, 394, 1075-1081.
113. Peláez, R.; Herrero, P.; Moreno, F. Nuclear export of the yeast hexokinase 2 protein requires the Xpo1 Crm1-dependent pathway. J. Biol. Chem. 2009, 284, 20548-20555.
114. Friis, R.M.; Wu, B.P.; Reinke, S.N.; Hockman, D.J.; Sykes, B.D.; Schultz, M.C. A glycolytic burst drives glucose induction of global histone acetylation by picNuA4 and SAGA. Nucleic. Acids Res. 2009, 37, 3969-3980.
115. Daran-Lapujade, P.; Rossell, S.; van Gulik, W.M.; Luttik, M.A.; de Groot, M.J.; Slijper, M.; Heck, A.J.; Daran, J.M.; de Winde, J.H.; Westerhoff, H.V., et al. The fluxes through glycolytic enzymes in Saccharomyces cerevisiae are predominantly regulated at posttranscriptional levels. Proc. Natl. Acad. Sci. USA 2007, 104, 15753-15758.
116. Chen, Z.; Odstrcil, E.A.; Tu, B.P.; McKnight, S.L. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 2007, 316, 1916-1919.
117. Hilton, J.; Walker, M.D. DNA strand scission and its repair following exposure of cells to inhibitors of oxidative phosphorylation. Biochem. Biophys. Res. Commun. 1977, 75, 909-914.
118. Fry, D.W. Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrations. Biochem. Pharmacol. 1990, 40, 1981-1988.
119. Dalrymple, G.V.; Sanders, J.L.; Baker, M.L.; Wilkinson, K.P. The effect of 2,4-dinitrophenol on the repair of radiation injury by L-cells. Radiat. Res. 1969, 37, 90-102.
120. Moss, A.J., Jr.; Dalrymple, G.V.; Sanders, J.L.; Wilkinson, K.P.; Nash, J.C. Dinitrophenol inhibits the rejoining of radiation-induced DNA breaks by L-cells. Biophys. J. 1971, 11, 158-174.
121. Wang, Z.; Wu, X.; Friedberg, E.C. Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1993, 90, 4907-4911.
122. Lagostera, M.; Guerrero, R.; Villaverde, A.; Barbé, J. Effect of adenine, cytidine and guanosine on the expression of the SOS system in Escherichia coli. J. Gen. Microbiol. 1985, 131, 113-118.
123. Thomas, D.C.; Roberts, J.D.; Kunkel, T.A. Heteroduplex repair in extracts of human HeLa cells. J. Biol. Chem. 1991, 266, 3744-3751.
124. Rapaport, E.; Garcia-Blanco, M.A.; Zamecnik, P.C. Regulation of DNA replication in S phase nuclei by ATP and ADP pools. Proc. Natl. Acad. Sci. USA 1979, 76, 1643-1647.
125. Laureti, L.; Selva, M.; Dairou, J.; Matic, I. Reduction of dNTP levels enhances DNA replication fidelity in vivo. DNA Repair 2013, 12, 300-305.
126. Wijker, J.E.; Jensen, P.R.; Snoep, J.L.; vaz Gomes, A.; Guiral, M.; Jongsma, A.P.; de Waal, A.; Hoving, S.; van Dooren, S.; van der Weijden, C.C., et al. Energy, control and DNA structure in the living cell. Biophys. Chem. 1995, 55, 153-165.
127. Singleton, M.R.; Wigley, D.B. Multiple roles for ATP hydrolysis in nucleic acid modifying enzymes. EMBO J. 2003, 22, 4579-4583.
128. Okorokov, A.L.; Milner, J. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes. Mol. Cell Biol. 1999, 19, 7501-7510.
129. Yang, J.G.; Narlikar, G.J. FRET-based methods to study ATP-dependent changes in chromatin structure. Methods 2007, 41, 291-295.
130. Varga-Weisz, P. ATP-dependent chromatin remodeling factors: Nucleosome shufflers with many missions. Oncogene 2001, 20, 3076-3085.
131. Laval, F. Effect of uncouplers on radiosensitivity and mutagenicity in x-irradiated mammalian cells. Proc. Natl. Acad. Sci. USA 1980, 77, 2702-2705.
132. Tahanian, E.; Peiro, S.; Annabi, B. Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells. J. Inflamm. Res. 2011, 4, 1-10.
133. Jonson, I.; Ougland, R.; Klungland, A.; Larsen, E. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells. Stem Cell Res. 2013, 11, 1264-1271.
134. Zhang, M.; Yang, C.; Liu, H.; Sun, Y. Induced pluripotent stem cells are sensitive to DNA damage. Genomics Proteomics Bioinform. 2013, 11, 320-326.
135. Tanori, M.; Pasquali, E.; Leonardi, S.; Casciati, A.; Giardullo, P.; de Stefano, I.; Mancuso, M.; Saran, A.; Pazzaglia, S. Developmental and oncogenic radiation effects on neural stem cells and their differentiating progeny in mouse cerebellum. Stem Cells 2013, 31, 2506-2516.
136. Nouspikel, T. Genetic instability in human embryonic stem cells: Prospects and caveats. Future Oncol. 2013, 9, 867-877.
137. Kenyon, J.; Gerson, S.L. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2007, 35, 7557-7565.
138. Morley, A.; Seshadri, R.; Trainor, K.; Sorrell, J. Is aplastic anaemia due to abnormality of DNA? Lancet 1978, 2, 9-12.
139. Gerson, S.L.; Trey, J.E.; Miller, K.; Benjamin, E. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors. Cancer Res. 1987, 47, 89-95.
140. Luo, L.Z.; Gopalakrishna-Pillai, S.; Nay, S.L.; Park, S.W.; Bates, S.E.; Zeng, X.; Iverson, L.E.; O'Connor, T.R. DNA repair in human pluripotent stem cells is distinct from that in non-pluripotent human cells. PLoS One 2012, 7, doi:10.1371/journal.pone.0030541.
141. Cousin, W.; Ho, M.L.; Desai, R.; Tham, A.; Chen, R.Y.; Kung, S.; Elabd, C.; Conboy, I.M. Regenerative capacity of old muscle stem cells declines without significant accumulation of DNA damage. PLoS One 2013, 8, doi:10.1371/journal.pone.0063528.
142. Pavlides, S.; Whitaker-Menezes, D.; Castello-Cros, R.; Flomenberg, N.; Witkiewicz, A.K.; Frank, P.G.; Casimiro, M.C.; Wang, C.; Fortina, P.; Addya, S., et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8, 3984-4001.
143. Sloan, E.K.; Ciocca, D.R.; Pouliot, N.; Natoli, A.; Restall, C.; Henderson, M.A.; Fanelli, M.A.; Cuello-Carrión, F.D.; Gago, F.E.; Anderson, R.L. Stromal cell expression of caveolin-1 predicts outcome in breast Cancer. Am. J. Pathol. 2009, 174, 2035-2043.
144. Whitaker-Menezes, D.; Martinez-Outschoorn, U.E.; Lin, Z.; Ertel, A.; Flomenberg, N.; Witkiewicz, A.K.; Birbe, R.C.; Howell, A.; Pavlides, S.; Gandara, R., et al. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011, 10, 1772-1783.
145. Balliet, R.M.; Capparelli, C.; Guido, C.; Pestell, T.G.; Martinez-Outschoorn, U.E.; Lin, Z.; Whitaker-Menezes, D.; Chiavarina, B.; Pestell, R.G.; Howell, A., et al. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production: Promoting breast cancer tumor growth, understanding the aging and cancer connection. Cell Cycle 2011, 10, 4065-4073.
146. Samudio, I.; Fiegl, M.; McQueen, T.; Clise-Dwyer, K.; Andreeff, M. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res. 2008, 68, 5198-5205.
147. Konopleva, M.; Andreeff, M. Targeting the leukemia microenvironment. Curr. Drug Targets 2007, 8, 685-701.
148. Wang, L.; O'Leary, H.; Fortney, J.; Gibson, L.F. Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood 2007, 110, 3334-3344.
149. Echtay, K.S.; Murphy, M.P.; Smith, R.A.; Talbot, D.A.; Brand, M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J. Biol. Chem. 2002, 277, 47129-47135.
150. Samudio, I.; Fiegl, M.; Andreeff, M. Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism. Cancer Res. 2009, 69, 2163-2166.
151. Pecqueur, C.; Bui, T.; Gelly, C.; Hauchard, J.; Barbot, C.; Bouillaud, F.; Ricquier, D.; Miroux, B.; Thompson, C.B. Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB J. 2008, 22, 9-18.
152. Harper, M.E.; Antoniou, A.; Villalobos-Menuey, E.; Russo, A.; Trauger, R.; Vendemelio, M.; George, A.; Bartholomew, R.; Carlo, D.; Shaikh, A., et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J. 2002, 16, 1550-1557.
153. Mattiasson, G.; Shamloo, M.; Gido, G.; Mathi, K.; Tomasevic, G.; Yi, S.; Warden, C.H.; Castilho, R.F.; Melcher, T.; Gonzalez-Zulueta, M., et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 2003, 9, 1062-1068.
154. Mintz, B.; Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1975, 72, 3585-3589.
155. Ruckenstuhl, C.; Büttner, S.; Carmona-Gutierrez, D.; Eisenberg, T.; Kroemer, G.; Sigrist, S.J.; Fröhlich, K.U.; Madeo, F. The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for Cancer. PLoS One 2009, 4, doi:10.1371/journal.pone.0004592.
156. Eguchi, Y.; Shimizu, S.; Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 1997, 57, 1835-1840.
157. Eguchi, Y.; Srinivasan, A.; Tomaselli, K.J.; Shimizu, S.; Tsujimoto, Y. ATP-dependent steps in apoptotic signal transduction. Cancer Res. 1999, 59, 2174-2181.
158. Shen, J.; Liu, X.; Yu, W.M.; Liu, J.; Nibbelink, M.G.; Guo, C.; Finkel, T.; Qu, C.K. A critical role of mitochondrial phosphatase Ptpmt1 in embryogenesis reveals a mitochondrial metabolic stressinduced differentiation checkpoint in embryonic stem cells. Mol. Cell Biol. 2011, 31, 4902-4916.
159. Lane, N.; Martin, W. The energetics of genome complexity. Nature 2010, 467, 929-934.
160. Navarro, A.; Boveris, A. Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease. J. Bioenerg. Biomembr. 2009, 41, 517-521.
161. Balaban, R.S.; Nemoto, S.; Finkel, T. Mitochondria, oxidants, and aging. Cell 2005, 120, 483-495.
162. Lonergan, T.; Brenner, C.; Bavister, B. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J. Cell Physiol. 2006, 208, 149-153.
163. Brown, G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 1992, 284, 1-13.
164. Thundathil, J.; Filion, F.; Smith, L.C. Molecular control of mitochondrial function in preimplantation mouse embryos. Mol. Reprod. Dev. 2005, 71, 405-413.
165. Van Blerkom, J. Mitochondria in early mammalian development. Semin. Cell Dev. Biol. 2009, 20, 354-364.
166. St John J.C.; Ramalho-Santos, J.; Gray, H.L.; Petrosko, P.; Rawe, V.Y.; Navara, C.S.; Simerly, C.R.; Schatten, G.P. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 2005, 7, 141-153.
167. St. John, J. The control of mtDNA replication during differentiation and development. Biochim. Biophys. Acta 2014, 1840, 1345-1354.
168. Holley, A.K.; Dhar, S.K.; Xu, Y.; St. Clair, D.K. Manganese superoxide dismutase: Beyond life and death. Amino Acids 2012, 42, 139-158.
169. Duttaroy, A.; Paul, A.; Kundu, M.; Belton, A. A SOD2 null mutation confers severely reduced adult life span in Drosophila. Genetics 2003, 165, 2295-2299.
170. Van Remmen, H.; Ikeno, Y.; Hamilton, M.; Pahlavani, M.; Wolf, N.; Thorpe, S.R.; Alderson, N.L.; Baynes, J.W.; Epstein, C.J.; Huang, T.T., et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genome 2003, 16, 29-37.
171. Olivotto, M.; Arcangeli, A.; Caldini, R.; Chevanne, M.; Cipolleschi, M.G.; Dello Sbarba, P. Metabolic aspects of cell cycle regulation in normal and cancer cells. Toxicol. Pathol. 1984, 12, 369-373.
172. Li, W.; Nichols, K.; Nathan, C.A.; Zhao, Y. Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors. Cancer Biomark. 2013, 13, 377-383.
173. Kuai, X.Y.; Ji, Z.Y.; Zhang, H.J. Mitochondrial uncoupling protein 2 expression in colon cancer and its clinical significance. World J. Gastroenterol. 2010, 16, 5773-5778.
174. Zhang, G.; Qu, Y.; Dang, S.; Yang, Q.; Shi, B.; Hou, P. Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients. Diagn. Pathol. 2013, 8, 173.
175. Criscuolo, F.; Mozo, J.; Hurtaud, C.; Nübel, T.; Bouillaud, F. UCP2, UCP3, avUCP, what do they do when proton transport is not stimulated? Possible relevance to pyruvate and glutamine metabolism. Biochim. Biophys. Acta 2006, 1757, 1284-1291.
176. Zhang, J.; Khvorostov, I.; Hong, J.S.; Oktay, Y.; Vergnes, L.; Nuebel, E.; Wahjudi, P.N.; Setoguchi, K.; Wang, G.; Do, A., et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 2011, 30, 4860-4873.
177. Simonnet, H.; Alazard, N.; Pfeiffer, K.; Gallou, C.; Béroud, C.; Demont, J.; Bouvier, R.; Schägger, H.; Godinot, C. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 2002, 23, 759-768.
178. Wallace, D.C. Mitochondria and Cancer. Nat. Rev. Cancer 2012, 12, 685-698.
179. Pokorný, J.; Jandová, A.; Nedbalová, M.; Jelínek, F.; Cifra, M.; Kučera, O.; Havelka, D.; Vrba, J.; Vrba, J., Jr.; Coček, A., et al. Mitochondrial metabolism-Neglected link of cancer transformation and treatment. Prague Med. Rep. 2012, 113, 81-94.
180. Dang, C.V. Links between metabolism and Cancer. Genes Dev. 2012, 26, 877-890.
181. Butow, R.A.; Avadhani, N.G. Mitochondrial signaling: The retrograde response. Mol. Cell 2004, 14, 1-15.
182. Miceli, M.V.; Jazwinski, S.M. Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: Implications for age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2005, 46, 1765-1773.
183. Jazwinski, S.M. The retrograde response links metabolism with stress responses, chromatin-dependent gene activation, and genome stability in yeast aging. Gene 2005, 354, 22-27.
184. Singh, K.K.; Kulawiec, M.; Still, I.; Desouki, M.M.; Geradts, J.; Matsui, S. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 2005, 354, 140-146.
185. Traven, A.; Wong, J.M.; Xu, D.; Sopta, M.; Ingles, C.J. Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant. J. Biol. Chem. 2001, 276, 4020-4027.
186. Veatch, J.R.; McMurray, M.A.; Nelson, Z.W.; Gottschling, D.E. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell 2009, 137, 1247-1258.
187. Erol, A. Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis. Med. Hypotheses 2005, 65, 525-529.
188. Kyle, J.L.; Riesen, W.H. Stress and cigarette smoke effects on lung mitochondrial phosphorylation. Arch. Environ. Health 1970, 21, 492-497.
189. Hoffmann, R.F.; Zarrintan, S.; Brandenburg, S.M.; Kol, A.; de Bruin, H.G.; Jafari, S.; Dijk, F.; Kalicharan, D.; Kelders, M.; Gosker, H.R., et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir. Res. 2013, 14, 97.
190. Sanchez-Alvarez, R.; Martinez-Outschoorn, U.E.; Lin, Z.; Lamb, R.; Hulit, J.; Howell, A.; Sotgia, F.; Rubin, E.; Lisanti, M.P. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: Implications for breast cancer prevention. Cell Cycle 2013, 12, 289-301.
191. Kiessling, K.H.; Pilström, L. Effect of ethanol on rat liver. I. Enzymatic and histological studies of liver mitochondria. Q. J. Stud. Alcohol 1966, 27, 189-200.
192. Syed, M.; Skonberg, C.; Hansen, S.H. Effect of some organic solvents on oxidative phosphorylation in rat liver mitochondria: Choice of organic solvents. Toxicol. in Vitro 2013, 27, 2135-2141.
193. Hadler, H.I.; Mueller, K.W. The disturbance of oxidative phosphorylation in rat liver mitochondria by the carcinogens 12-hydroxystearic acid and its methyl ester. J. Environ. Pathol. Toxicol. 1978, 1, 75-85.
194. Parkin, D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 118, 3030-3044.
195. Koike, K. Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett. 2009, 286, 60-68.
196. Clippinger, A.J.; Bouchard, M.J. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J. Virol. 2008, 82, 6798-6811.
197. D'Agostino, D.M.; Bernardi, P.; Chieco-Bianchi, L.; Ciminale, V. Mitochondria as functional targets of proteins coded by human tumor viruses. Adv. Cancer Res. 2005, 94, 87-142.
198. Koura, M.; Isaka, H.; Yoshida, M.C.; Tosu, M.; Sekiguchi, T. Suppression of tumorigenicity in interspecific reconstituted cells and cybrids. Gann 1982, 73, 574-580.
199. Israel, B.A.; Schaeffer, W.I. Cytoplasmic suppression of malignancy. In Vitro Cell Dev. Biol. 1987, 23, 627-632.
200. Howell, A.N.; Sager, R. Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines. Proc. Natl. Acad. Sci. USA 1978, 75, 2358-2362.
201. McKinnell, R.G.; Deggins, B.A.; Labat, D.D. Transplantation of pluripotential nuclei from triploid frog tumors. Science 1969, 165, 394-396.
202. Li, L.; Connelly, M.C.; Wetmore, C.; Curran, T.; Morgan, J.I. Mouse embryos cloned from brain tumors. Cancer Res. 2003, 63, 2733-2736.
203. Hochedlinger, K.; Blelloch, R.; Brennan, C.; Yamada, Y.; Kim, M.; Chin, L.; Jaenisch, R. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 2004, 1815, 1875-1885.
204. Petros, J.A.; Baumann, A.K.; Ruiz-Pesini, E.; Amin, M.B.; Sun, C.Q.; Hall, J.; Lim, S.; Issa, M.M.; Flanders, W.D.; Hosseini, S.H., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA 2005, 102, 719-724.
205. Wang, T.; Marquardt, C.; Foker, J. Aerobic glycolysis during lymphocyte proliferation. Nature 1976, 261, 702-705.
206. Brand, K.; Aichinger, S.; Forster, S.; Kupper, S.; Neumann, B.; Nürnberg, W.; Ohrisch, G. Cell-cycle-related metabolic and enzymatic events in proliferating rat thymocytes. Eur. J. Biochem. 1988, 172, 695-702.
207. Siverio, J.M.; Torres, N.V.; Meléndez-Hevia, E. Activities of L-lactate and glycerol phosphate production rates in vitro from glucose 6-phosphate in regenerating rat liver. Int. J. Biochem. 1985, 17, 1015-1017.
208. Forni, E.; Filipazzi, A. Study of some aspects of liver regeneration after partial hepatectomy. I. Oxigen consumption and glycolysis of regenerating tissue. Chir. Patol. Sper. 1964, 12, 263-267.
209. Menyhárt, J.; Horváth, A.; Rosta, A. A reliable index of tissue metabolic activity during the initial phase of rat liver regeneration. Acta Biochim. Biophys. Acad. Sci. Hung. 1971, 6, 139-144.
210. Vihersaari, T.; Kivisaari, J.; Ninikoski, J. Effect of changes in inspired oxygen tension on wound metabolism. Ann. Surg. 1979, 179, 889-895.
211. Braskén, P.; Renvall, S. Local energy metabolism in healing colon anastomosis. An enzyme-histochemical study in rats. Acta Chir. Scand. 1990, 156, 565-570.
212. O'Connor, R.J. The effect on cell division of inhibiting aerobic glycolysis. Br. J. Exp. Pathol. 1950, 31, 449-453.
213. Bax, B.E.; Bloxam, D.L. Energy metabolism and glycolysis in human placental trophoblast cells during differentiation. Biochim. Biophys. Acta 1997, 1319, 283-292.
214. Kwon, H.J. ATP oscillations mediate inductive action of FGF and SHH signalling on prechondrogenic condensation. Cell Biochem. Funct. 2013, 31, 75-81.
215. Tsuchiya, M.; Ross, J. Advantages of external periodic events to the evolution of biochemical oscillatory reactions. Proc. Natl. Acad. Sci. USA 2003, 100, 9691-9695.
216. Boiteux, A.; Goldbeter, A.; Hess, B. Control of oscillating glycolysis of yeast by stochastic, periodic, and steady source of substrate: A model and experimental study. Proc. Natl. Acad. Sci. USA 1975, 72, 3829-3833.
217. Yang, J.H.; Yang, L.; Qu, Z.; Weiss, J.N. Glycolytic oscillations in isolated rabbit ventricular myocytes. J. Biol. Chem. 2008, 283, 36321-36327.
218. Agathocleous, M.; Love, N.K.; Randlett, O.; Harris, J.J.; Liu, J.; Murray, A.J.; Harris, W.A. Metabolic differentiation in the embryonic retina. Nat. Cell Biol. 2012, 14, 859-864.
219. Ho, J.; de Moura, M.B.; Lin, Y.; Vincent, G.; Thorne, S.; Duncan, L.M.; Hui-Min, L.; Kirkwood, J.M.; Becker, D.; van Houten, B. et al. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol. Cancer 2012, 11, 76.
220. Maglietta, R.; Liuzzi, V.C.; Cattaneo, E.; Laczko, E.; Piepoli, A.; Panza, A.; Carella, M.; Palumbo, O.; Staiano, T.; Buffoli, F., et al. Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer 2012, 12, 608.
221. Brown, N.J.; Higham, S.E.; Perunovic, B.; Arafa, M.; Balasubramanian, S.; Rehman, I. Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers. PLoS One 2013, 8, doi:10.1371/journal.pone.0057697.
222. Kim, S.; Kim do, H.; Jung, W.H.; Koo, J.S. Metabolic phenotypes in triple-negative breast Cancer. Tumour Biol. 2012, 34, 1699-1712.
223. Yadava, N.; Schneider, S.S.; Jerry, D.J.; Kim, C. Impaired mitochondrial metabolism and mammary carcinogenesis. J. Mammary Gland Biol. Neoplasia. 2013, 18, 75-87.
224. Buravkova, L.B.; Rylova, Y.V.; Andreeva, E.R.; Kulikov, A.V.; Pogodina, M.V.; Zhivotovsky, B.; Gogvadze, V. Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells. Biochim. Biophys. Acta 2013, 1830, 4418-4425.
225. Xun, Z.; Lee, D.Y.; Lim, J.; Canaria, C.A.; Barnebey, A.; Yanonne, S.M.; McMurray, C.T. Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells. Mech. Ageing Dev. 2012, 133, 176-185.
226. Saumet, A.; Vetter, G.; Bouttier, M.; Antoine, E.; Roubert, C.; Orsetti, B.; Theillet, C.; Lecellier, C.H. Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells. Mol. Biosyst. 2012, 8, 3242-3253.
227. Heinrich, R.; Meléndez-Hevia, E.; Montero, F.; Nuño, J.C.; Stephani, A.; Waddell, T.G. The structural design of glycolysis: An evolutionary approach. Biochem. Soc. Trans. 1999, 27, 294-298.
228. Van Dijken, J.P.; Weusthuis, R.A.; Pronk, J.T. Kinetics of growth and sugar consumption in yeasts. Antonie Van Leeuwenhoek. 1993, 63, 343-352.
229. Inderlied, C.B.; Sypherd, P.S. Glucose metabolism and dimorphism in Mucor. J. Bacteriol. 1978, 133, 1282-1286.
230. Poolman, B. Energy transduction in lactic acid bacteria. FEMS Microbiol. Rev. 1993, 12, 125-147.
231. Veech, R.L.; Kashiwaya, Y.; Gates, D.N.; King, M.T.; Clarke, K. The energetics of ion distribution: The origin of the resting electric potential of cells. IUBMB Life 2002, 54, 241-252.
232. Veech, R.L.; Kashiwaya, Y.; King, M.T. The resting membrane potential of cells are measures of electrical work, not of ionic currents. Integr. Physiol. Behav. Sci. 1995, 30, 283-307.
233. Masuda, T.; Dobson, G.P.; Veech, R.L. The Gibbs-Donnan near-equilibrium system of heart. J. Biol. Chem. 1990, 265, 20321-20334.
234. Racker, E. Why do tumor cells have a high aerobic glycolysis? J. Cell Physiol. 1976, 89, 697-700.
235. Schmidt, H.; Siems, W.; Müller, M.; Dumdey, R.; Rapoport, S.M. ATP-producing and consuming processes of Ehrlich mouse ascites tumor cells in proliferating and resting phases. Exp. Cell Res. 1991, 194, 122-127.
236. Termonia, Y.; Ross, J. Oscillations and control features in glycolysis: Numerical analysis of a comprehensive model. Proc. Natl. Acad. Sci. USA 1981, 78, 2952-2956.
237. Ganitkevich, V.; Mattea, V.; Benndorf, K. Glycolytic oscillations in single ischemic cardiomyocytes at near anoxia. J. Gen. Physiol. 2010, 135, 307-319.
238. Ahsan, H.; Halpern, J.; Kibriya, M.G.; Pierce, B.L.; Tong, L.; Gamazon, E.; McGuire, V.; Felberg, A.; Shi, J.; Jasmine, F., et al. A Genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol. Biomark. Prev. 2014, 23, 658-669.
239. Klarer, A.C.; O'Neal, J.; Imbert-Fernandez, Y.; Clem, A.; Ellis, S.R.; Clark, J.; Clem, B.; Chesney, J.; Telang, S. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism. Cancer Metab. 2014, 23, 2.
240. Goldbeter, A. Oscillatory enzyme reactions and Michaelis-Menten kinetics. FEBS Lett. 2013, 587, 2778-2784.
241. Mahnensmith, R.L.; Aronson, P.S. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ. Res. 1985, 56, 773-788.
242. Sennoune, S.R.; Bakunts, K.; Martínez, G.M.; Chua-Tuan, J.L.; Kebir, Y.; Attaya, M.N.; Martínez-Zaguilán, R. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: Distribution and functional activity. Am. J. Physiol. Cell Physiol. 2004, 286, C1443-C1452.
243. Baluch, S.; Midwood, C.J.; Griffiths, J.R.; Stubbs, M.; Coombes, R.C. Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS. Br. J. Cancer 1991, 63, 901-904.
244. Navon, G.; Ogawa, S.; Shulman, R.G.; Yamane, T. 31P nuclear magnetic resonance studies of Ehrlich ascites tumor cells. Proc. Natl. Acad. Sci. USA 1977, 74, 87-91.
245. Ross, B.D.; Higgins, R.J.; Boggan, J.E.; Knittel, B.; Garwood, M. 31P NMR spectroscopy of the in vivo metabolism of an intracerebral glioma in the rat. Magn. Reson. Med. 1988, 6, 403-417.
246. Bradbury, D.A.; Simmons, T.D.; Slater K.J.; Crouch S.P. Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J. Immunol. Methods 2000, 240, 79-92.
247. Singer, S.; Souza, K.; Thilly, W.G. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: A 31P- and 13C- nuclear magnetic resonance (NMR) spectroscopy study. Cancer Res. 1995, 55, 5140-5145.
248. Rizwan, A.; Serganova, I.; Khanin, R.; Karabeber, H.; Ni, X.; Thakur, S.; Zakian, K.L.; Blasberg, R.; Koutcher, J.A. Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors. Clin. Cancer Res. 2013, 19, 5158-5169.
249. Park, J.M.; Park, J.H. Human in vivo 31P MR spectroscopy of benign and malignant breast tumors. Korean J. Radiol. 2001, 2, 80-86.
250. Golinska, M.; Troy, H.; Chung, Y.L.; McSheehy, P.M.; Mayr, M.; Yin, X.; Ly, L.; Williams, K.J.; Airley, R.E.; Harris, A.L. et al. Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer 2011, 11, 198.
251. Cho, Y.M.; Kwon, S.; Pak, Y.K.; Seol, H.W.; Choi, Y.M.; Park, D.J.; Park, K.S.; Lee, H.K. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 2006, 348, 1472-1478.
252. Lonergan, T.; Bavister, B.; Brenner, C. Mitochondria in stem cells. Mitochondrion 2007, 7, 289-296.
253. Hoffer, F.A.; Taylor, G.A.; Spevak, M.; Ingber, D.; Fenton, T. Metabolism of tumor regression from angiogenesis inhibition: 31P magnetic resonance spectroscopy. Magn. Reson. Med. 1989, 11, 202-208.
254. Vlashi, E.; Lagadec, C.; Vergnes, L.; Matsutani, T.; Masui, K.; Poulou, M.; Popescu, R.; della Donna, L.; Evers, P.; Dekmezian, C. et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc. Natl. Acad. Sci. USA 2011, 108, 16062-16067.
255. Frieden, B.R.; Gatenby, R.A. Information dynamics in living systems, prokaryotes: Eukaryotes, and cancer. PLoS One 2011, 6, doi:10.1371/journal.pone.0022085.
256. Teschendorff, A.E.; Severini, S. Increased entropy of signal transduction in the cancer metastasis phenotype. BMC Syst. Biol. 2010, 4, 104.
257. West, J.; Lacasa, L.; Severini, S.; Teschendorff, A. Approximate entropy of network parameters. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 2012, 85, doi:10.1103/PhysRevE.85.046111.
258. Banerji, C.R.; Severini, S.; Teschendorff, A.E. Network transfer entropy and metric space for causality inference. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 2013, 87, doi:10.1103/PhysRevE.87.052814.
259. Banerji, C.R.; Miranda-Saavedra, D.; Severini, S.; Widschwendter, M.; Enver, T.; Zhou, J.X.; Teschendorff, A.E. Cellular network entropy as the energy potential in Waddington's differentiation landscape. Sci. Rep. 2013, 3, 3039.
260. Ozernyuk, N.D.; Zotin, A.I.; Yurowitzky, Y.G. Deviation of the living system from the stationary state during oogenesis. Wilhelm Roux Archiv 1973, 172, 66-74.
261. Zotin, A.A.; Zotin, A.I. Phenomenological theory of ontogenesis. Int. J. Dev. Biol. 1997, 41, 917-921.
262. Martyushev, L.M. Entropy and entropy production: Old misconceptions and new breakthroughs. Entropy 2013, 151, 152-170.
263. Kumar, P.; Rajput, S.; Verma, A.; De, S.; Datta, T.K. Expression pattern of glucose metabolism genes in relation to development rate of buffalo (Bubalus bubalis) oocytes and in vitro-produced embryos. Theriogenology 2013, 80, 914-922.
264. Sugimura, S.; Matoba, S.; Hashiyada, Y.; Aikawa, Y.; Ohtake, M.; Matsuda, H.; Kobayashi, S.; Konishi, K.; Imai, K. Oxidative phosphorylation-linked respiration in individual bovine oocytes. J. Reprod. Dev. 2012, 58, 636-641.
265. Abele, D. Toxic oxygen: The radical life-giver. Nature 2002, 420, 27.
266. Houghton, J.; Morozov, A.; Smirnova, I.; Wang, T.C. Stem cells and Cancer. Semin. Cancer Biol. 2007, 17, 191-203.
267. DePinho, R.A. The age of cancer. Nature 2000, 408, 248-254.
268. Armitage, P.; Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 2004, 91, 1983-1989.
269. Fanali, C.; Lucchetti, D.; Farina, M.; Corbi, M.; Cufino, V.; Cittadini, A.; Sgambato, A. Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives. World J. Gastroenterol. 2014, 20, 923-942.
270. Trosko, J.E. Induction of iPS cells and of cancer stem cells: The stem cell or reprogramming hypothesis of cancer? Anat. Rec. 2014, 297, 161-173.
271. Agathocleous, M.; Harris, W.A. Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol. 2013, 23, 484-492.
272. Smith-Vikos, T. A report of the James Watson lecture at Yale University. Yale J. Biol. Med. 2012, 85, 417-419.
273. Pierce, G.B. Neoplasms, differentiations and mutations. Am. J. Pathol. 1974, 77, 103-118.
274. DeBerardinis, R.J.; Thompson, C.B. Cellular metabolism and disease: What do metabolic outliers teach us? Cell 2012, 148, 1132-1144.
275. Santin, G.; Paulis, M.; Vezzoni, P.; Pacchiana, G.; Bottiroli, G.; Croce, A.C. Autofluorescence properties of murine embryonic stem cells during spontaneous differentiation phases. Lasers Surg. Med. 2013, 45, 597-607.
276. Warburg, O.; Gawehn, K.; Geissler, A.W.; Lorenz, S. On the transformation of embryonal metabolism into cancer metabolism. Hoppe. Seylers. Z. Physiol. Chem. 1960, 321, 252-257.
277. Fliedner, S.M.; Kaludercic, N.; Jiang, X.S.; Hansikova, H.; Hajkova, Z.; Sladkova, J.; Limpuangthip, A.; Backlund, P.S.; Wesley, R.; Martiniova, L., et al. Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: Insights from a mouse cell model applied to human tumor tissue. PLoS One 2012, 7, doi:10.1371/journal.pone.0040949.
278. Seppet, E.; Gruno, M.; Peetsalu, A.; Gizatullina, Z.; Nguyen, H.P.; Vielhaber, S.; Wussling, M.H.; Trumbeckaite, S.; Arandarcikaite, O.; Jerzembeck, D., et al. Mitochondria and energetic depression in cell pathophysiology. Int. J. Mol. Sci. 2009, 10, 2252-2303.
279. Xu, T.; Zhao, J.; Hu, P.; Dong, Z.; Li, J.; Zhang, H.; Yin, D.; Zhao, Q. Pentachlorophenol exposure causes Warburg-like effects in zebrafish embryos at gastrulation stage. Toxicol. Appl. Pharmacol. 2014, 277, 183-191.
280. Campos, B.; Gal, Z.; Baader, A. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. J. Pathol. 2014, 2014, doi:10.1002/path.4366.
281. Jiang, Y.; Zhou, X.; Chen, X.; Yang, G.; Wang, Q.; Rao, K.; Xiong, W.; Yuan, J. Benzo(a)pyrene induced mitochondrial dysfunction and cell death in p53-null Hep3B Cells. Mutat. Res. 2011, 726, 75-83.
282. Pavanello, S.; Dioni, L.; Hoxha, M.; Fedeli, U.; Mielzynska-Svach, D.; Baccarelli, A.A. Mitochondrial DNA copy number and exposure to polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomark. Prev. 2013, 22, 1722-1729.
283. Xie, Y.; Zhong, C.; Zeng, M.; Guan, L.; Luo, L. Effect of hexavalent chromium on electron leakage of respiratory chain in mitochondria isolated from rat liver. Cell Physiol. Biochem. 2013, 31, 473-485.
284. Liu, G.; Cheresh, P.; Kamp, D.W. Molecular basis of asbestos-induced lung disease. Annu. Rev. Pathol. 2013, 8, 161-187.